Helixgate https://validator.w3.org/feed/docs/rss2.html Lilly’s $25B+ M&A spree captures half of pharma’s 2026 capacity Home An obesity drug deep-dive, and peptides move mainstream GSK to Acquire Nuvalent for $10.6B, Boosting Cancer Pipeline with Precision NSCLC Treatments RFK Jr. claims his calendar is publicly available. We’ve been trying to get it for a year Nonprofit buys experimental cancer drug to maintain patient access Potential Cocaine Addiction Targets Identified Through Genetic Mapping in Rats Origins of First Eukaryotes Linked to Contributions from Multiple Bacteria and Giant Viruses New mRNA Delivery Platform Restores Muscle Function in DMD Models STAT+: Abridge inks deals with Nvidia and Lilly Summit pulls $500M share sale a day after announcing it Fighting Antimicrobial Resistance with Biomaterials and Phages Symeres Expands Spray Drying Capabilities at Its U.S. New Jersey Site Sensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy Genentech R&D layoffs hit top exec who’s been with the biotech nearly 30 years STAT+: Novartis doubles down on molecular glue strategy DaltonTx launches AI drug discovery platform  Sky-high Parabilis, Kailera IPOs spur optimism—but only for derisked biotechs Gorilla Adenovirus Brings Natural Edge to Cancer Therapy Takeda’s AI-designed pill bests BMS’ Sotyktu in head-to-head psoriasis trial STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and more STAT+: Enliven Therapeutics’ leukemia drug shows promise in new study SonoThera bags $125M series B to advance safer gene therapies Novartis tightens bond with Orionis in up to $1.4B molecular glue deal Takeda’s $4B TYK2 drug tops Bristol Myers’ Sotyktu in head-to-head test GLP-1 reduces liver fat by 63%, trial results show  Opinion: How long Covid’s scientific stalemate made it politically erasable Portugal, Spain and the new biotech frontier May layoffs hit nearly 7,000, with most cuts from Takeda, BioNTech The wait continues: pressure to operate lean among factors behind slow job market Diabetes association leader apologizes for expulsion of members, pledges to rebuild trust STAT+: Your sepsis algorithm shouldn’t require a time machine In Silico Devices May Improve Drug Manufacturability Ethyreal starts up with $101M and takes aim at a pair of immune diseases Sanofi stops immune drug trial in latest research setback OB-GYN association, deviating from CDC guidance, issues its own vaccine recommendations mRNA Tails Play Key Role in Folding Regulatory Proteins STAT+: Pharmalittle: We’re reading about U.S. pressure on European drug prices, longer shortages, and more Sanofi cans late-stage study for rare autoimmune disease on underwhelming efficacy Disc’s FDA meeting sets ‘clear path’ for embattled rare blood disease drug The State of Biologics Testing 2026 Update: Parabilis raises industry-record $670M IPO DOJ reaches second settlement on youth gender care Lilly bets up to $1B+ with AlzeCure in search for next Alzheimer’s act ASCO wins from RevMed, Akeso/Summit, more; plus more Lilly and more China; ADA on deck STAT+: As the U.S. looks on, European countries feel growing pressure on drug prices Opinion: Even in abortion-protecting states, teens face unnecessary barriers to care Local trade groups must support life sciences in these difficult times STAT+: Private Medicare plans erect barriers to rehab care in pursuit of profit, federal investigators find Spatial CRISPR screens map total RNA in tissue